Theralase Technologies Stock Revenue
| TLT Stock | CAD 0.26 0.01 3.70% |
Theralase Technologies fundamentals help investors to digest information that contributes to Theralase Technologies' financial success or failures. It also enables traders to predict the movement of Theralase Stock. The fundamental analysis module provides a way to measure Theralase Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theralase Technologies stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 1.1 M | 1.5 M |
Theralase | Revenue |
Theralase Technologies Company Revenue Analysis
Theralase Technologies' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Theralase Technologies Revenue | 1.07 M |
Most of Theralase Technologies' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theralase Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Theralase
Projected quarterly revenue analysis of Theralase Technologies provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Theralase Technologies match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Theralase Technologies' stock price.
Theralase Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Theralase Technologies is extremely important. It helps to project a fair market value of Theralase Stock properly, considering its historical fundamentals such as Revenue. Since Theralase Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theralase Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theralase Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Theralase Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Theralase Technologies reported 1.07 M of revenue. This is 99.99% lower than that of the Health Care Equipment & Supplies sector and 99.96% lower than that of the Health Care industry. The revenue for all Canada stocks is 99.99% higher than that of the company.
Theralase Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theralase Technologies' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Theralase Technologies could also be used in its relative valuation, which is a method of valuing Theralase Technologies by comparing valuation metrics of similar companies.Theralase Technologies is currently under evaluation in revenue category among its peers.
Theralase Technologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of Theralase Technologies from analyzing Theralase Technologies' financial statements. These drivers represent accounts that assess Theralase Technologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theralase Technologies' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 49.2M | 38.8M | 77.6M | 66.5M | 39.6M | 23.4M | |
| Enterprise Value | 36.8M | 31.0M | 74.0M | 65.5M | 39.9M | 21.8M |
Theralase Fundamentals
| Return On Equity | -2.39 | ||||
| Return On Asset | -0.82 | ||||
| Operating Margin | (11.30) % | ||||
| Current Valuation | 65.65 M | ||||
| Shares Outstanding | 245.54 M | ||||
| Shares Owned By Insiders | 8.70 % | ||||
| Number Of Shares Shorted | 42.79 K | ||||
| Price To Earning | (9.79) X | ||||
| Price To Book | 30.70 X | ||||
| Price To Sales | 71.32 X | ||||
| Revenue | 1.07 M | ||||
| Gross Profit | 628.17 K | ||||
| EBITDA | (4.31 M) | ||||
| Net Income | (4.57 M) | ||||
| Cash And Equivalents | 1.67 M | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 386.88 K | ||||
| Current Ratio | 3.45 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (4.07 M) | ||||
| Short Ratio | 0.06 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 1.2 | ||||
| Beta | 1.35 | ||||
| Market Capitalization | 66.3 M | ||||
| Total Asset | 3.28 M | ||||
| Retained Earnings | (63.24 M) | ||||
| Working Capital | 421.43 K | ||||
| Net Asset | 3.28 M |
About Theralase Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theralase Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theralase Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theralase Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.